Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths—agonizing, from diseases or infections the body might otherwise fight off—sent loved ones into the streets, ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Explore how sexually transmitted infections progress, symptoms to watch for, and prevention strategies to protect sexual ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Your treatment and how successful it is depends on how advanced the cancer is (the stage), your CD4 count, and whether or not you've had other AIDS-related infections. NHL doesn't always need to ...

it seems clear that a more complete understanding of the mechanisms that have enabled natural SIV infections to avoid disease progression may provide major clues for the design of successful AIDS ...

Here, integrating ribosome profiling, RNA-seq and proteomics to reveal transcriptional and post-translational regulation in HIV-infected T cells, the authors show that non-AUG translation of viral ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

HIV targets the immune system and invades T cells, which are white blood cells that fight infection. The virus then replicates (makes copies of itself), and the cells burst open. They release many ...